These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36858273)

  • 21. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles.
    Ozçakir HT; Levi R; Tavmergen E; Göker EN
    J Obstet Gynaecol Res; 2004 Apr; 30(2):100-4. PubMed ID: 15009611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated Analysis of Transcriptome and Histone Modifications in Granulosa Cells During Ovulation in Female Mice.
    Shirafuta Y; Tamura I; Ohkawa Y; Maekawa R; Doi-Tanaka Y; Takagi H; Mihara Y; Shinagawa M; Taketani T; Sato S; Tamura H; Sugino N
    Endocrinology; 2021 Sep; 162(9):. PubMed ID: 34171084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
    De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
    Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated hypothalamic aromatization at the onset of precocious puberty in transgenic female mice hypersecreting human chorionic gonadotropin: effect of androgens.
    Gonzalez B; Ratner LD; Scerbo MJ; Di Giorgio NP; Poutanen M; Huhtaniemi IT; Calandra RS; Lux-Lantos VA; Cambiasso MJ; Rulli SB
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):102-11. PubMed ID: 24755422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression differences induced by equimolar low doses of LH or hCG in combination with FSH in cultured mouse antral follicles.
    Segers I; Adriaenssens T; Wathlet S; Smitz J
    J Endocrinol; 2012 Nov; 215(2):269-80. PubMed ID: 22906696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels.
    Ahtiainen P; Sharp V; Rulli SB; Rivero-Müller A; Mamaeva V; Röyttä M; Huhtaniemi I
    Endocr Relat Cancer; 2010 Sep; 17(3):611-21. PubMed ID: 20453081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.
    Couse JF; Bunch DO; Lindzey J; Schomberg DW; Korach KS
    Endocrinology; 1999 Dec; 140(12):5855-65. PubMed ID: 10579351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
    Thau R
    Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new parameter for the evaluation of premature luteinization: the pre-ovulatory molecular relation between serum concentrations of progesterone and estradiol].
    Kably Ambe A; Méndez Espinosa G; Barrón Vallejo J
    Ginecol Obstet Mex; 1998 May; 66():208-13. PubMed ID: 9646578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological properties of a novel follicle-stimulating hormone/human chorionic gonadotropin chimeric gonadotropin.
    Garone LM; Ammannati E; Brush TS; Fischer DJ; Tos EG; Luo J; Altobello KL; Ciampolillo C; Ihley TM; Kurosawa E; Tiebout A; McKenna S
    Endocrinology; 2006 Sep; 147(9):4205-12. PubMed ID: 16794004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin-mediated progesterone secretion by cultured rat granulosa cells: regulation by purified human glycoprotein hormones and their subunits.
    Grasso P; Crisp TM
    Endocrinology; 1985 Jan; 116(1):319-27. PubMed ID: 2578034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
    Mann RJ; Keri RA; Nilson JH
    Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
    McPherson JC; Costoff A; Mahesh VB
    Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.
    Faraoni EY; Camilletti MA; Abeledo-Machado A; Ratner LD; De Fino F; Huhtaniemi I; Rulli SB; Díaz-Torga G
    J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.
    Choi J; Smitz J
    Gynecol Endocrinol; 2014 Mar; 30(3):174-81. PubMed ID: 24283620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine and molecular milieus of ovarian follicles are diversely affected by human chorionic gonadotropin and gonadotropin-releasing hormone in prepubertal and mature gilts.
    Ziecik AJ; Klos J; Gromadzka-Hliwa K; Dietrich MA; Slowinska M; Likszo P; Knapczyk-Stwora K; Gajewski Z; Kaczmarek MM
    Sci Rep; 2021 Jun; 11(1):13465. PubMed ID: 34188064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroidogenic Factor 1 Regulation of the Hypothalamic-Pituitary-Ovarian Axis of Adult Female Mice.
    Smith OE; Roussel V; Morin F; Ongaro L; Zhou X; Bertucci MC; Bernard DJ; Murphy BD
    Endocrinology; 2022 Apr; 163(4):. PubMed ID: 35247045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine alterations and signaling changes associated with declining ovarian function and advanced biological aging in follicle-stimulating hormone receptor haploinsufficient mice.
    Danilovich N; Javeshghani D; Xing W; Sairam MR
    Biol Reprod; 2002 Aug; 67(2):370-8. PubMed ID: 12135869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.